Momenta Phama (MNTA) Announces FDA Marketing Approval of Glatopa ANDA
Tweet Send to a Friend
Momenta Phama (NASDAQ: MNTA) announced that the U.S. Food and Drug Administration has granted marketing approval of Sandoz's Abbreviated New ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE